Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir
创新随机 I 期研究和给药方案选择，以加速和指导 Nirmatrelvir 的关键 COVID-19 试验
期刊:Clinical Pharmacology & Therapeutics
影响因子:6.3
doi:10.1002/cpt.2603
Ravi Shankar P Singh, Sima S Toussi, Frances Hackman, Phylinda L Chan, Rohit Rao, Richard Allen, Lien Van Eyck, Sylvester Pawlak, Eugene P Kadar, Frances Clark, Haihong Shi, Annaliesa S Anderson, Michael Binks, Sandeep Menon, Gianluca Nucci, Arthur Bergman
